Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2000
11/30/2000WO2000071556A1 Prodrug activation using catalytic antibodies
11/30/2000WO2000071555A2 509rr
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071543A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000WO2000071541A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071524A1 2-nh-pyridones and pyrimidones as mrs inhibitors
11/30/2000WO2000071523A1 Antibiotic prodrugs
11/30/2000WO2000071522A1 Benzimidazole derivatives and their use as methionyl t-rna synthetase inhibitors
11/30/2000WO2000071161A1 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferative drugs
11/30/2000WO2000071159A1 Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections
11/30/2000WO2000071158A1 Tagged epitope protein transposable element
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071149A2 Therapeutic uses of bpi protein products in humans with otitis media with effusion
11/30/2000WO2000071146A2 Glutathione reductase for therapy and prophylaxis of aids
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071139A2 Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
11/30/2000WO2000071131A1 Hexacyclic g-csf mimetics
11/30/2000WO2000071130A1 Hexacyclic g-csf mimetics
11/30/2000WO2000071126A1 Quinoxaline containing medicaments for post exposure prophylaxis of an hiv infection
11/30/2000WO2000071120A1 Antibacterial compounds
11/30/2000WO2000071078A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000043037A3 Hiv-encoded chemoattractant
11/30/2000WO2000043014A3 Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000041547A3 Methods of promoting or enhancing interleukin-12 production through administration of thalidomide
11/30/2000WO2000040605A3 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
11/30/2000WO2000040261A3 Vaccination method for efficient induction of cytotoxic t lymphocyte response
11/30/2000WO2000040241A3 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
11/30/2000WO2000037096A3 Treatment of hepatitis c virus infections with interleukin-10
11/30/2000WO2000034481A3 DRUG TARGETS IN $i(CANDIDA ALBICANS)
11/30/2000WO2000033814A3 Method for administering agents to the central nervous system
11/30/2000WO2000032520A9 Method for activating water and use of activated water of this type
11/30/2000WO2000027363A9 Aerosols comprising nanoparticle drugs
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway
11/30/2000CA2838395A1 Combination neisserial compositions
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2375072A1 Prodrug activation using catalytic antibodies
11/30/2000CA2375066A1 Antibiotic prodrugs
11/30/2000CA2375032A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000CA2374941A1 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000CA2374938A1 Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374714A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374550A1 Antigenic neisserial peptides
11/30/2000CA2374070A1 Tagged epitope protein transposable element
11/30/2000CA2373991A1 Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections
11/30/2000CA2373751A1 Isoflavonoid methylation enzyme
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373262A1 Therapeutic uses of bpi protein products in humans with otitis media with effusion
11/30/2000CA2373236A1 Combination neisserial compositions
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054988A1 Anti-viral vectors
11/29/2000EP1054971A2 Group b streptococcus antigens
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054953A1 NOVEL pgsA
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054896A1 ANALGESIC PEPTIDES FROM VENOM OF $i(GRAMMOSTOLA SPATULATA) AND USE THEREOF
11/29/2000EP1054889A1 New oxazolidinones with azol-containing tricycles
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054874A1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
11/29/2000EP1054870A1 Heterocyclic topoisomerase poisons
11/29/2000EP1054867A1 Antivirals
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054689A1 Strategically modified hepatitis b core proteins and their derivatives
11/29/2000EP1054683A1 Modified heat shock protein-antigenic peptide complex
11/29/2000EP1054681A1 The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
11/29/2000EP1054674A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/29/2000EP1054591A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
11/29/2000EP0749323B1 Methods for modulating t cell anergy
11/29/2000CN1275164A Neisseria lactoferrin binding protein
11/29/2000CN1275129A Oligosaccharide derivatives and process for producing the same
11/29/2000CN1275084A Recombinant porcine adenovirus vector
11/29/2000CN1274578A Preparation of Azithromycin solution and semi-solid
11/29/2000CN1058880C Compound antibacterial and antiviral veterinary medicine capable of raising immunity
11/29/2000CN1058876C Huanghuafuyanling (oral) capsule containing goldenrod for treating gynaecology inflammation
11/29/2000CN1058870C Wenxianglu smedicinal liquid for curing cold
11/29/2000CN1058868C Long-effect and broad-spectrum antibiotic granules and making method of its products thereof
11/29/2000CN1058866C Medicinal composition for treating tinea manus and pedis
11/29/2000CN1058865C Cream for treating tinea cruris
11/28/2000US6153751 Preparing the antiviral b-isomer of a 1,3-oxathiolane nucleoside by reacting in presence of stannic chloride
11/28/2000US6153736 Modified ether glyceroglycolipids
11/28/2000US6153731 Dehydrodidemnin B
11/28/2000US6153642 Useful as antineoplastic and antiviral agents
11/28/2000US6153609 Arylsulfonylamino hydroxamic acid derivatives
11/28/2000US6153595 Composition and method for treatment of CMV infections
11/28/2000US6153594 5'-O-acylated antiviral nucleosides
11/28/2000US6153580 For generating an immune response in host
11/28/2000US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation
11/28/2000US6153406 Transforming escherichia coli cells with vector coding for protein and selectable marker, culturing in media containing glucose and selection agent, protein is expressed and found in inclusion bodies
1 ... 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 ... 1798